Abstract
Brevetoxins (PbTxs) are polyether ladder-shaped neurotoxins produced by the dinoflagellate Karenia brevis. Blooms of K. brevis have been recorded since the mid-1800s, principally in the Gulf of Mexico but occasionally along the mid and south Atlantic coasts. Blooms may be accompanied by public health issues as well as significant mortalities of marine mammals, such as bottlenose dolphins and manatees, fishes, sea birds, and sea turtles. PbTxs bind to the voltage-gated sodium channels (VGSCs), leading to persistent activation of neuronal, muscle, and cardiac cells. In humans, after consumption of contaminated shellfish (oysters, clams, whelks), these toxins cause a syndrome known as neurotoxic shellfish poisoning (NSP), characterized by nausea, diarrhea, vomiting, abdominal pain, paresthesia, myalgia, ataxia, bradycardia, loss of coordination, vertigo, and mydriasis. The ingestion of contaminated seafood represents the most dangerous route of exposure for humans. However, when PbTxs are aerosolized through the disruption of K. brevis cells by breaking waves or winds, people can suffer from respiratory effects such as conjunctivitis, rhinorrhea, and bronchoconstriction. Due to successful shellfish monitoring programs managed by the Gulf coast states, cases of human intoxications are fortunately rather rare, and no human fatalities have been attributed to NSP.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baden DG, Bourdelais AJ, Jacocks H, Michelliza S, Naar J. Natural and derivative brevetoxins: historical background, multiplicity, and effects. Environ Health Perspect. 2005;113(5):621–5.
Benson J, Hahn F, March T, McDonald J, Sopori M, Seagrave J, Gomez A, Bourdelais A, Naar J, Zaias J, Bossart G, Baden D. Inhalation of brevetoxin 3 in rats exposed for 5 days. J Toxicol Environ Health A. 2004;67:1443–56.
Benson JM, Hahn FF, March TH, McDonald JD, Gomez AP, Sopori MJ, Boudelais AJ, Naar J, Zaias J, Bossart GD, Baden DG. Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days. Environ Health Perspect. 2005;113:626–31.
Bossart GD, Baden DG, Ewing RY, Roberts B, Wright SD. Brevetoxicosis in manatees (Trichechus manatus latirostris) from the 1996 epizootic: gross, histologic, and immunohistochemical features. Toxicol Pathol. 1998;26(2):276–82.
Brand E, Campbell L, Bresnan E. Karenia: the biology and ecology of a toxic genus. Harmful Algae. 2012;14:156–78.
Dechraoui MY, Wang Z, Ramsdell JS. Intrinsic potency of synthetically prepared brevetoxin cysteine metabolites BTX-B2 and desoxyBTX-B2. Toxicon. 2007;50(6):825–34.
Feinstein A, Ceurvels AR, Hutton RF, Snoek E. Red tide outbreaks off the Florida west coast. Coral Gables: The Marine Laboratory, University of Miami; 1955. pp. 55–15
Flewelling LJ, Naar JP, Abbott JP, Baden DG, Barros NB, Bossart GD, et al. Brevetoxicosis: red tides and marine mammal mortalities. Nature. 2005;435(7043):755–6.
Gawley RE, Rein KS, Jeglitsch G, Adams DJ, Theodorakis EA, Tiebes J, Nicolaou KC, Baden DG. The relationship of brevetoxin ‘length’ and A-ring functionality to binding and activity in neuronal sodium channels. Chem Biol. 1995;2(8):533–41.
Hoagland P, Jin D, Beet A, Kirkpatrick B, Reich A, Ullmann S, Fleming LE, Kirkpatrick G. The human health effects of Florida red tide (FRT) blooms: an expanded analysis. Environ Int. 2014;68:144–53.
Isbister GK, Kiernan MC. Neurotoxic marine poisoning. Lancet Neurol. 2005;4:218–28.
Kemppainen BW, Reifenrath WG, Stafford RG, Mehta M. Methods for in vitro skin absorption studies of a lipophilic toxin produced by red tide. Toxicology. 1991;66(1):1–17.
Kirkpatrick B, Fleming LE, Squicciarini D, Backer LC, Clark R, Abraham W, Benson J, Cheng YS, Johnson D, Pierce R, Zaias J, Bossart GD, Baden DG. Literature review of Florida red tide: implications for human health effects. Harmful Algae. 2004;3(2):99–115.
Landsberg JH. The effects of harmful algal blooms on aquatic organisms. Rev Fish Sci. 2002;10:113–390.
Landsberg JH, Flewelling LJ, Naar J. Karenia brevis red tides, brevetoxins in the food web, and impacts on natural resources: decadel advancements. Harmful Algae. 2009;8:598–607.
Leighfield TA, Muha N, Ramsdell JS. Brevetoxin B is a clastogen in rats, but lacks mutagenic potential in the SP-98/100 Ames test. Toxicon. 2009;54(6):851–6.
Leighfield TA, Muha N, Ramsdell JS. Tissue distribution of amino acid- and lipid-brevetoxins after intravenous administration to C57BL/6 mice. Chem Res Toxicol. 2014;27(7):1166–75.
Lin YY, Risk M. Isolation and structure of brevetoxin B from the “red tide” dinoflagellate Ptychodiscus brevis (Gymnodinium breve). J Am Chem Soc. 1981;103:6773–5.
Morris PD, Campbell DS, Taylor TJ, Freeman JI. Clinical and epidemiological features of neurotoxic shellfish poisoning in North Carolina. Am J Public Health. 1991;81(4):471–4.
Murrell RN, Gibson JE. Brevetoxins 2, 3, 6, and 9 show variability in potency and cause significant induction of DNA damage and apoptosis in Jurkat E6-1 cells. Arch Toxicol. 2009;83(11):1009–19.
Plakas SM, Dickey RW. Advances in monitoring and toxicity assessment of brevetoxins in molluscan shellfish. Toxicon. 2010;56(2):137–49.
Poli MA. Brevetoxins: pharmacology, toxicokinetics and detection. In: Fingerman M, Nagabhushanam R, editors. Recent advances in marine biothecnology. volume 7: seafood safety and human health, Chap 1. Enfield: Science Publisher; 2002.
Poli MA, Mende TJ, Baden DG. Brevetoxins, unique activators of voltage-sensitive sodium channels, bind to specific sites in rat brain synaptosomes. Mol Pharmacol. 1986;30(2):129–35.
Poli MA, Templeton CB, Thompson WL, Hewetson JF. Distribution and elimination of brevetoxin PbTx-3 in rats. Toxicon. 1990;28(8):903–10.
Poli MA, Musser SM, Dickey RW, Eilers PP, Hall S. Neurotoxic shellfish poisoning and brevetoxin metabolites: a case study from Florida. Toxicon. 2000;38(7):981–93.
Purkerson-Parker SL, Fieber LA, Rein KS, Podona T, Baden DG. Brevetoxin derivatives that inhibit toxin activity. Chem Biol. 2000;7(6):385–93.
Ramsdell JS. The molecular and integrative basis to brevetoxin toxicity. In: Botana LM, editor. Seafood and freshwater toxins: pharmacology, physiology, and detection. 2nd ed. Boca Raton: CRC Press; 2008.
Rein KS, Baden DG, Gawley RE. Conformational analysis of the sodium channel modulator, brevetoxin A, comparison with brevetoxin B conformations, and a hypothesis about the common pharmacophore of the “site 5” toxins. J Org Chem. 1994a;59(8):2101–6.
Rein KS, Lynn B, Gawley RE, Baden DG, Brevetoxin B. Chemical modifications, synaptosome binding, toxicity, and an unexpected conformational effect. J Org Chem. 1994b;59:2107–13.
Shen M, Xu J, Tsang TY, Au DW. Toxicity comparison between Chattonella marina and Karenia brevis using marine medaka (Oryzias melastigma): evidence against the suspected ichthyotoxins of Chattonella marina. Chemosphere. 2010;80(5):585–91.
Shimizu Y, Chou HN, Bando H, Van Duyne G, Clardy J. Structure of brevetoxin A (GB-1 toxin), the most potent toxin in the Florida red tide organism Gymnodinium breve (Ptychodiscus brevis). J Am Chem Soc. 1986;108(3):514–5.
Tian L, Wang M, Li X, Lam PK, Wang M, Wang D, Chou HN, Li Y, Chan LL. Proteomic modification in gills and brains of medaka fish (Oryzias melastigma) after exposure to a sodium channel activator neurotoxin, brevetoxin-1. Aquat Toxicol. 2011;104(3–4):211–7.
Tibbetts BM, Baden DG, Benson JM. Uptake, tissue distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation. J Toxicol Environ Health A. 2006;69(14):1325–35.
Trainer VL, Thomsen WJ, Catterall WA, Baden DG. Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes. Mol Pharmacol. 1991;40(6):988–94.
Trainer VL, Baden DG, Catterall WA. Identification of peptide components of the brevetoxin receptor site of rat brain sodium channels. J Biol Chem. 1994;269(31):19904–9.
van Apeldorn ME, van Egmond HP, Speijers GJA. Neurotoxic shellfish poisoning: a review. RIVM Report 388802023. Bilthoven: National Institute for Public Health and the Environment; 2001. pp. 1–70.
Wang Z, Ramsdell JS. Analysis of interactions of brevetoxin-B and human serum albumin by liquid chromatography/mass spectrometry. Chem Res Toxicol. 2011;24(1):54–64.
Watkins M, Reich A, Fleming E, Hammond R. Neurotoxic shellfish poisoning. Mar Drugs. 2008;6:431–55.
Woofter RT, Ramsdell JS. Distribution of brevetoxin to lipoproteins in human plasma. Toxicon. 2007;49(7):1010–8.
Woofter RT, Spiess PC, Ramsdell JS. Distribution of brevetoxin (PbTx-3) in mouse plasma: association with high-density lipoproteins. Environ Health Perspect. 2005;113(11):1491–6.
Zaias J, Fleming LE, Baden DG, Abraham WM. Repeated exposure to aerosolized brevetoxin-3 induces prolonged airway hyperresponsiveness and lung inflammation in sheep. Inhal Toxicol. 2011;23(4):205–11.
Zhang F, Xu X, Li T, Liu Z. Shellfish toxins targeting voltage-gated sodium channels. Mar Drugs. 2013;11:4698–723.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht (outside the USA)
About this entry
Cite this entry
Brovedani, V., Pelin, M., D’Orlando, E., Poli, M. (2016). Brevetoxins: Toxicological Profile. In: Gopalakrishnakone, P., Haddad Jr., V., Tubaro, A., Kim, E., Kem, W. (eds) Marine and Freshwater Toxins. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6419-4_22
Download citation
DOI: https://doi.org/10.1007/978-94-007-6419-4_22
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6418-7
Online ISBN: 978-94-007-6419-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences